We are live on ! Find out more
CS

Candriam SCA Portfolio holdings

AUM $19.3B
1-Year Est. Return 39.18%
This Fund
S&P 500
This Quarter Est. Return
+11.68%
1 Year Est. Return
+39.18%
3 Year Est. Return
+109.85%
5 Year Est. Return
+149.31%
10 Year Est. Return
+617.16%
AUM
$19.1B
AUM Growth
+$1.76B
Cap. Flow
+$154M
Cap. Flow %
0.81%
Top 10 Hldgs %
32.12%
Holding
703
New
28
Increased
257
Reduced
281
Closed
39

Top Buys

Rank Stock Value
1
NU icon
Nu Holdings
NU
+$60.7M
2
JNJ icon
Johnson & Johnson
JNJ
+$58.3M
3
SCHW
Charles Schwab
SCHW
+$54M
4
ABBV icon
AbbVie
ABBV
+$52.9M
5
PANW icon
Palo Alto Networks
PANW
+$42.9M

Top Sells

Rank Stock Value
1
NVDA icon
NVIDIA
NVDA
+$92.7M
2
EMR icon
Emerson Electric
EMR
+$57.2M
3
MELI icon
Mercado Libre
MELI
+$48.9M
4
AVGO icon
Broadcom
AVGO
+$38.9M
5
MU icon
Micron Technology
MU
+$37.7M

Sector Composition

Rank Sector Weight
1 Technology 36.63%
2 Healthcare 23.08%
3 Financials 11.48%
4 Consumer Discretionary 7.78%
5 Communication Services 6.93%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
WM icon
26
Waste Management
WM
$95.9B
$128M 0.67%
581,442
-69,263
-11% -$15.6M
AMGN icon
27
Amgen
AMGN
$203B
$126M 0.66%
445,220
-60,500
-12% -$17.5M
BSX icon
28
Boston Scientific
BSX
$65.8B
$122M 0.64%
1,247,471
+411,446
+49% +$42.6M
ISRG icon
29
Intuitive Surgical
ISRG
$121B
$121M 0.63%
270,080
-63,466
-19% -$30.5M
MRK icon
30
Merck
MRK
$324B
$119M 0.62%
1,419,161
-234,938
-14% -$19.4M
JNJ icon
31
Johnson & Johnson
JNJ
$635B
$118M 0.62%
636,024
+340,354
+115% +$58.3M
ZTS icon
32
Zoetis
ZTS
$31.6B
$115M 0.6%
784,345
+189,505
+32% +$28.6M
ICE icon
33
Intercontinental Exchange
ICE
$82.4B
$114M 0.6%
675,280
+213,459
+46% +$38.1M
A icon
34
Agilent Technologies
A
$39.1B
$113M 0.59%
882,230
+348,764
+65% +$42.1M
MU icon
35
Micron Technology
MU
$1.04T
$97.2M 0.51%
580,820
-294,336
-34% -$37.7M
ALNY icon
36
Alnylam Pharmaceuticals
ALNY
$36.3B
$96.9M 0.51%
212,416
-25,668
-11% -$10.5M
WAB icon
37
Wabtec
WAB
$51.1B
$96.8M 0.51%
482,986
+17,960
+4% +$3.54M
REGN icon
38
Regeneron Pharmaceuticals
REGN
$68.8B
$95.3M 0.5%
169,495
+27,287
+19% +$15.4M
BKNG icon
39
Booking.com
BKNG
$138B
$93.2M 0.49%
431,425
+62,475
+17% +$13.9M
CDNS icon
40
Cadence Design Systems
CDNS
$90B
$90.2M 0.47%
256,889
+23,256
+10% +$8M
DHR icon
41
Danaher
DHR
$135B
$88.2M 0.46%
444,856
-7,077
-2% -$1.41M
NFLX icon
42
Netflix
NFLX
$292B
$87.7M 0.46%
731,490
+8,440
+1% +$1.03M
ADSK icon
43
Autodesk
ADSK
$44.3B
$87.1M 0.46%
274,147
-33,629
-11% -$10.2M
CSCO icon
44
Cisco
CSCO
$450B
$86.9M 0.46%
1,270,551
-10,136
-0.8% -$691K
PGR icon
45
Progressive
PGR
$124B
$86.1M 0.45%
348,804
+19,849
+6% +$4.89M
ECL icon
46
Ecolab
ECL
$75.6B
$83.6M 0.44%
305,213
+1,440
+0.5% +$391K
TJX icon
47
TJX Companies
TJX
$170B
$82M 0.43%
567,088
-55,214
-9% -$7.34M
XYL icon
48
Xylem
XYL
$28.5B
$82M 0.43%
555,602
+57,559
+12% +$7.98M
AXP icon
49
American Express
AXP
$223B
$80.7M 0.42%
242,912
-72,817
-23% -$23.2M
UNH icon
50
UnitedHealth
UNH
$382B
$80.5M 0.42%
233,272
+38,075
+20% +$11.5M

Similar funds

Candriam SCA's Q3 2025 Portfolio in Review

As of Q3 2025, Candriam SCA held 703 positions worth $19.1B, up 10% from $17.3B the previous quarter. Its ten largest holdings account for 32% of the portfolio.

Candriam SCA's Q3 2025 filing shows 28 new, 257 increased, 281 reduced and 39 closed positions. Its largest new stake was Banco Macro: 322,600 shares worth $13.6M. The largest sale was NVIDIA, an estimated $92.7M.

By sector, the portfolio is most concentrated in Technology at 37% of assets, up from 36% a quarter earlier, followed by Healthcare and Financials.

  • Candriam SCA's largest Q3 2025 buy was Banco Macro: 322,600 shares worth $13.6M.
  • Candriam SCA added most to Nu Holdings in Q3 2025, an estimated $60.7M increase.
  • Candriam SCA's biggest Q3 2025 reduction was NVIDIA, cutting an estimated $92.7M.
  • Candriam SCA fully exited Verona Pharma in Q3 2025, selling an estimated $20.5M.
  • Candriam SCA's ten largest holdings make up 32% of its $19.1B portfolio in Q3 2025.
  • Candriam SCA opened 28 new positions and closed 39 in Q3 2025.
  • Candriam SCA's portfolio value rose 10% quarter-over-quarter to $19.1B.

Based on Candriam SCA's 13F filing for Q3 2025, filed 6 Nov 2025.